What is Flunarizine?

Category: Prescription Drugs

Most popular types: Sibelium Zinasen

false

Flunarizine, an international medication is a calcium channel blocker. It is used to prevent migraine headache.

Reported purpose & perceived effectiveness
Purpose Patients Evaluations Perceived Effectiveness
Migraine 4 2
Headaches 3 5
Migraine headaches 2 2
Cerebral vasospasm 1 0
Difficulty staying asleep 1 0
Insomnia 1 0

Show all 9 reasons taken


  • Major
  • Moderate
  • Slight
  • None
  • Can't tell

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations Percentage
Severe 4
Moderate 0
Mild 3
None 2

Commonly reported side effects and conditions associated with Flunarizine

Side effect Patients Percentage
Dizziness 1
Dry mouth 1
Headaches 1
Heart palpitations 1
Nausea 1
Night sweats 1

Show all 9 reported side effects

Dosages

Based on patients currently taking Flunarizine

Dosage Patients Percentage
3 tablet(s) monthly 1
5 mg daily 1

Why patients stopped taking Flunarizine

Multiple reasons could be selected

Reason Patients Percentage
Side effects too severe 3
Course of treatment ended 2
Did not seem to work 2
Doctor's advice 1
See all 6 patients who've stopped taking Flunarizine

Duration

Currently taking Flunarizine

Duration Patients Percentage
1 - 2 years 1
2 - 5 years 1

Stopped taking Flunarizine

Duration Patients Percentage
Less than 1 month 1
1 - 6 months 1
6 months - 1 year 3
1 - 2 years 1
Adherence
Adherence Evaluations Percentage
Always 7
Usually 1
Sometimes 0
Never taken as prescribed 1
Burden
Burden Evaluations Percentage
Very hard to take 1
Somewhat hard to take 0
A little hard to take 1
Not at all hard to take 7
Cost per month
Cost per month Evaluations Percentage
$200+ 0
$100-199 0
$50-99 0
$25-49 0
< $25 1
Not specified 8

What people switch to and from

Patients started taking Flunarizine after stopping:

Treatment Patients Percentage
Propranolol (Inderal) 1
Verapamil (Verapamil ER) 1
Last updated:
There are no evaluations for Flunarizine.